Clinical Trial Update: FARE Peanut SLIT and Early Tolerance Induction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for FARE Peanut SLIT evaluating early tolerance induction in individuals with peanut hypersensitivity and related food allergies; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy
• Peanut Hypersensitivity

Drugs mentioned

• FARE Peanut SLIT (peanut sublingual immunotherapy)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Peanut Hypersensitivity, Food Allergy | Phase 2 | Status: COMPLETED | Results posted: 2021-12-16